Health
High Dose Favipiravir Countered SARS-CoV-2 in Hamsters, Hydroxychloroquine Ineffective – Global Biodefense
Virologists at the Rega Institute have shown that the anti-malaria drug hydroxychloroquine does not limit SARS-CoV-2 coronavirus replication in hamsters.
Virologists at the Rega Institute have shown that the anti-malaria drug hydroxychloroquine does not limit SARS-CoV-2 coronavirus replication in hamsters. A high dose of the anti-flu drug favipiravir, by contrast, has an antiviral effect in the hamsters. The team published their findings in this week in the Proceedings of the National Academy of Sciences (PNAS).
Virologists at the KU Leuven Rega Institute have been working on two lines of SARS-CoV-2 research: searching for a vaccine to prevent …
-
General13 hours agoQantas terminal at Melbourne Airport evacuated and flights delayed due to fire
-
Business17 hours agoWhy this ASX 200 tech stock could rise 20%
-
Business19 hours ago3 of the best ASX ETFs for beginners to buy with $1,000
-
General18 hours agoCone of Silence. Is secret Aussie spy in Rex Patrick case a man or a woman?